| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P50 | author | Renda Wiener | Q43124102 |
| P2093 | author name string | Robin J Larson | |
| Daniel C Wiener | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | glucose | Q37525 |
| meta-analysis | Q815382 | ||
| P304 | page(s) | 933-944 | |
| P577 | publication date | 2008-08-01 | |
| P1433 | published in | The Journal of the American Medical Association | Q1470970 |
| P1476 | title | Benefits and risks of tight glucose control in critically ill adults: a meta-analysis | |
| P478 | volume | 300 |
| Q37991763 | "One more thing to think about…" Cognitive burden experienced by intensive care unit nurses when implementing a tight glucose control protocol |
| Q37070157 | A comparison study of continuous insulin infusion protocols in the medical intensive care unit: computer-guided vs. standard column-based algorithms |
| Q33873421 | A disparity between physician attitudes and practice regarding hyperglycemia in pediatric intensive care units in the United States: a survey on actual practice habits |
| Q95642478 | A performance score of the quality of inpatient diabetes care is a marker of clinical outcomes and suggests a cause-effect relationship between hypoglycemia and the risk of in-hospital mortality |
| Q45918212 | A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. |
| Q37689888 | A review of perioperative glucose control in the neurosurgical population |
| Q28282265 | A systematic assessment of cardiovascular outcomes in the saxagliptin drug development program for type 2 diabetes |
| Q42758581 | A tight glycemic control initiative in a surgical intensive care unit and hospitalwide |
| Q48433965 | A.S.P.E.N. Clinical Guidelines: nutrition support of the critically ill child |
| Q27023234 | AKI associated with cardiac surgery |
| Q89660872 | Accuracy of Blood Glucose Measurement and Blood Glucose Targets |
| Q47291063 | Accuracy of Capillary and Arterial Whole Blood Glucose Measurements Using a Glucose Meter in Patients under General Anesthesia in the Operating Room |
| Q38667382 | Acute Kidney Injury in Cardiac Surgery and Cardiac Intensive Care |
| Q82764894 | Acute kidney injury |
| Q37189275 | American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control |
| Q37689869 | An overview of hypoglycemia in the critically ill. |
| Q37453073 | An overview of preoperative glucose evaluation, management, and perioperative impact |
| Q34030816 | Analyses of longitudinal, hospital clinical laboratory data with application to blood glucose concentrations. |
| Q42109086 | Analysis: Continuous glucose monitoring during intensive insulin therapy |
| Q37421672 | Analysis: New point-of-care blood glucose monitoring system for the hospital demonstrates satisfactory analytical accuracy using blood from critically ill patients--an important step toward improved blood glucose control in the hospital |
| Q36159127 | Analytic characteristics of three Bayer contour blood glucose monitoring systems in neonates |
| Q30411034 | Analytic evaluation of a new glucose meter system in 15 different critical care settings |
| Q37813868 | Analytic review: glucose controversies in the ICU. |
| Q84952106 | Anti-inflammatory effects of perioperative intensive insulin therapy during cardiac surgery with cardiopulmonary bypass |
| Q37538736 | Artificial pancreas: an emerging approach to treat Type 1 diabetes |
| Q30422225 | Assessing inpatient glycemic control: what are the next steps? |
| Q91768301 | Association of multiple glycemic parameters at intensive care unit admission with mortality and clinical outcomes in critically ill patients |
| Q38679524 | Autoregressive Modeling of Drift and Random Error to Characterize a Continuous Intravascular Glucose Monitoring Sensor |
| Q35581034 | Barriers and facilitators to the use of computer-based intensive insulin therapy |
| Q34420039 | Benchmarking glucose results through automation: the 2009 Remote Automated Laboratory System Report |
| Q35912958 | Best Practices for Interdisciplinary Care Management by Hospital Glycemic Teams: Results of a Society of Hospital Medicine Survey Among 19 U.S. Hospitals |
| Q37232412 | Blood glucose concentration for predicting poor outcomes in patients with and without impaired glucose metabolism undergoing off-pump coronary artery bypass surgery - long-term observational study |
| Q43299645 | Blood glucose control among critically ill patients with brain injury. |
| Q22305498 | Blood glucose control in patients with severe sepsis and septic shock |
| Q37689894 | Blood glucose control in the trauma patient |
| Q52877010 | Blood glucose control using a computer-guided glucose management system in allogeneic hematopoietic cell transplant recipients. |
| Q39111653 | Blood glucose dysregulation and cognitive outcome in ARDS survivors. |
| Q46094875 | Blood glucose in acute stroke |
| Q24200451 | Blood glucose target levels for critically ill adult patients |
| Q30371026 | Case scenario: a patient on dual antiplatelet therapy with an intracranial hemorrhage after percutaneous coronary intervention |
| Q34807345 | Characteristics and effects of nurse dosing over-rides on computer-based intensive insulin therapy protocol performance |
| Q37404433 | Cleveland Clinic cardiovascular intensive care unit insulin conversion protocol |
| Q37765323 | Clinical review: Strict or loose glycemic control in critically ill patients--implementing best available evidence from randomized controlled trials |
| Q38819246 | Comparison between a novel and conventional artificial pancreas for perioperative glycemic control using a closed-loop system. |
| Q42086161 | Comparison of intensive insulin therapy versus conventional glucose control in traumatic brain injury patients on parenteral nutrition: A pilot randomized clinical trial |
| Q42821800 | Comparison of modified preadmission glucose-lowering regimen with basal/bolus regimen for glucose control on outcome in general medicine wards |
| Q41865388 | Computerized intensive insulin dosing can mitigate hypoglycemia and achieve tight glycemic control when glucose measurement is performed frequently and on time |
| Q47380919 | Continuous Glucose Monitoring Measures Can Be Used for Glycemic Control in the ICU: An In-Silico Study |
| Q41886516 | Continuous Insulin Infusion: When, Where, and How? |
| Q84218640 | Continuous insulin infusion is associated with a reduced post-surgical length of stay, but not with the complication rate, in patients with diabetes mellitus undergoing coronary artery bypass graft |
| Q43250301 | Controversies in host defense against surgical site infection. |
| Q43769298 | Correlation of early postoperative blood glucose levels with postoperative complications, hospital costs, and length of hospital stay in patients with gastrointestinal malignancies |
| Q38343001 | Creating a perioperative glycemic control program |
| Q37231391 | Critical care nephrology: Core Curriculum 2009. |
| Q98772346 | Critical components for designing and implementing randomized controlled trials |
| Q37991761 | Critical illness hyperglycemia in pediatric cardiac surgery |
| Q40425736 | Current state of glycemic control in critically ill subjects in a general intensive care unit |
| Q38824570 | Current topics in glycemic control by wearable artificial pancreas or bedside artificial pancreas with closed-loop system |
| Q42743862 | Defining Medical Futility and Improving Medical Care |
| Q37292552 | Derangements in blood glucose following initial resuscitation from in-hospital cardiac arrest: a report from the national registry of cardiopulmonary resuscitation |
| Q40388971 | Design and rationale of Heart and Lung Failure - Pediatric INsulin Titration Trial (HALF-PINT): A randomized clinical trial of tight glycemic control in hyperglycemic critically ill children |
| Q38725471 | Development of a cross-disciplinary continuous insulin infusion protocol for non-critically ill patients in a French university hospital. |
| Q33606011 | Diabetes and poor disease control: is comorbid depression associated with poor medication adherence or lack of treatment intensification? |
| Q34718512 | Diabetes treatment and cardiovascular safety |
| Q36263218 | Diabetes-specific enteral nutrition formula in hyperglycemic, mechanically ventilated, critically ill patients: a prospective, open-label, blind-randomized, multicenter study |
| Q33753500 | Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). |
| Q27024676 | Diagnosis, management and treatment of glucometabolic disorders emerging after kidney transplantation: a position statement from the Nordic Transplantation Societies |
| Q35141204 | Diagonal earlobe crease and coronary artery disease in a Chinese population |
| Q33742893 | Does intensive insulin therapy really reduce mortality in critically ill surgical patients? A reanalysis of meta-analytic data. |
| Q44850027 | Duration of time on intensive insulin therapy predicts severe hypoglycemia in the surgically critically ill population |
| Q47763499 | Early goal-directed nutrition versus standard of care in adult intensive care patients: the single-centre, randomised, outcome assessor-blinded EAT-ICU trial |
| Q40914054 | Effect of blood-sugar limitation on intensive care mortality: Intragroup evaluation |
| Q42164798 | Effect of intensive insulin therapy using a closed-loop glycemic control system in hepatic resection patients: a prospective randomized clinical trial |
| Q51002816 | Effect of perioperative intensive insulin therapy for liver dysfunction after hepatic resection. |
| Q42795401 | Effects of Moderate Intensity Glycemic Control After Cardiac Surgery |
| Q33547478 | Effects of blood glucose transcription mismatches on a computer-based intensive insulin therapy protocol |
| Q39816946 | Effects of peri-operative glucose levels on adverse outcomes in infants receiving open-heart surgery for congenital heart disease with cardiopulmonary bypass |
| Q64900626 | Effects of perioperative tight glycemic control on postoperative outcomes: a meta-analysis. |
| Q38059485 | Endocrine and metabolic emergencies: hypoglycaemia |
| Q39436159 | Energy, Protein, Carbohydrate, and Lipid Intakes and Their Effects on Morbidity and Mortality in Critically Ill Adult Patients: A Systematic Review. |
| Q37694790 | Essential elements of the native glucoregulatory system, which, if appreciated, may help improve the function of glucose controllers in the intensive care unit setting |
| Q37734465 | Evaluating laboratory diagnostic tests and translational research |
| Q38033155 | Evaluation of an adult insulin infusion protocol at an academic medical center. |
| Q48294153 | Evidence-based critical care medicine: seeing through a glass darkly |
| Q35237363 | Extreme Stress Hyperglycemia During Acute Illness in a Pediatric Emergency Department |
| Q38169038 | Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association |
| Q37080649 | Failure to control hyperglycemia in noncritically ill diabetes patients despite standard glycemic management in a hospital setting |
| Q51379434 | Fasting hyperglycaemia and in-hospital mortality in elderly population. |
| Q41973756 | Glucose Information for Tight Glycemic Control: Different Methods with Different Challenges |
| Q37155281 | Glucose Meter Use in the Intensive Care Unit: Much Ado About Something |
| Q37635820 | Glucose control and its implications for the general surgeon. |
| Q44304664 | Glucose control and mortality in patients with severe traumatic brain injury |
| Q37637818 | Glucose control in the older patient: from intensive, to effective and safe |
| Q35247256 | Glucose control: how low should you go with the critically ill? |
| Q37939881 | Glucose elevations and outcome in critically injured trauma patients |
| Q37778246 | Glucose management in the neurosurgical patient: are we yet any closer? |
| Q38142955 | Glucose metabolism in critically ill patients: are incretins an important player? |
| Q37833518 | Glucose variability measures and their effect on mortality: a systematic review |
| Q50352538 | Glycaemic control in paediatric critical care |
| Q37551038 | Glycated hemoglobin A: A predictor of outcome in trauma admissions to intensive care unit |
| Q42241723 | Glycemia management in critical care patients |
| Q37376834 | Glycemic control and diabetes management in hospitalized patients in Brazil |
| Q43295247 | Glycemic control and insulin safety: the impact of computerized intravenous insulin dosing |
| Q37586246 | Glycemic control for postoperative pediatric cardiac patients |
| Q47154512 | Glycemic control in acute illness. |
| Q37640683 | Glycemic control in critically ill patients. |
| Q37689882 | Glycemic control in the burn intensive care unit: focus on the role of anemia in glucose measurement |
| Q38956796 | Glycemic control, mortality, and hypoglycemia in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials |
| Q30426632 | Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus |
| Q43784073 | Hemodynamic resuscitation in septic shock: cardiovascular support and adjunctive therapy |
| Q98774622 | Hemoglobin A1C is a Predictor of COVID-19 Severity in Patients with Diabetes |
| Q47768742 | High Glucose Variability in Hospitalized Patients with Type 1 Diabetes Mellitus |
| Q42096952 | Higher Blood Glucose within the Normal Range Is Associated with More Severe Strokes |
| Q90618923 | Hospital outcomes and cumulative burden from complications in type 2 diabetic sepsis patients: a cohort study using administrative and hospital-based databases |
| Q46053500 | How to manage hyperglycemia in an acute coronary syndrome patient |
| Q38704977 | Hyperglycemia and Acute Kidney Injury During the Perioperative Period |
| Q36810316 | Hyperglycemia and perioperative glucose management |
| Q37453066 | Hyperglycemia in critical illness: a review |
| Q43485103 | Hyperglycemia in critical illness: lessons from NICE-SUGAR. |
| Q34002421 | Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis |
| Q45964649 | Hyperglycemic kidney damage in an animal model of prolonged critical illness. |
| Q43144594 | Hyperinsulinemia predicts survival in a hyperglycemic mouse model of critical illness |
| Q36422751 | Hyperlactatemia affects the association of hyperglycemia with mortality in nondiabetic adults with sepsis |
| Q45753818 | Hypoglycaemia and predisposing factors among clinical subgroups treated with intensive insulin therapy |
| Q36783714 | Hypoglycemia and cardiovascular risks |
| Q36782795 | Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society |
| Q38123733 | Hypoglycemia as a driver of cardiovascular risk in diabetes |
| Q42862372 | Hypoglycemia in the critically ill: how low is too low? |
| Q35435686 | Hypoglycemia-associated mortality is not drug-associated but linked to comorbidities |
| Q41828479 | Hypothesis: Intensive insulin therapy-induced mortality is due to excessive serotonin autoinhibition and autonomic dysregulation |
| Q37649682 | Impact of a quality improvement project on deceased organ donor management |
| Q35662694 | Impact of chemically-modified tetracycline 3 on intertwined physiological, biochemical, and inflammatory networks in porcine sepsis/ARDS. |
| Q34102968 | Impact of glycemic control on the incidence of acute kidney injury in critically ill patients: a comparison of two strategies using the RIFLE criteria |
| Q37099164 | Impact of intraoperative hyperglycaemia on renal dysfunction after off-pump coronary artery bypass |
| Q44677581 | Impact of shock requiring norepinephrine on the accuracy and reliability of subcutaneous continuous glucose monitoring |
| Q34080578 | Implementing glucose control in intensive care: a multicenter trial using statistical process control |
| Q37391407 | In Silico Testing of an Artificial-Intelligence-Based Artificial Pancreas Designed for Use in the Intensive Care Unit Setting |
| Q38603367 | In-hospital metabolic regulation in patients with a diabetic foot ulcer: is it worthwhile? |
| Q37742952 | Induced hypothermia for trauma: current research and practice |
| Q44708534 | Influence of HbA1c levels on platelet function profiles associated with tight glycemic control in patients presenting with hyperglycemia and an acute coronary syndrome. A subanalysis of the CHIPS Study ("Control de HIperglucemia y Actividad Plaqueta |
| Q35994777 | Influence of a strict glucose protocol on serum potassium and glucose concentrations and their association with mortality in intensive care patients |
| Q27694547 | Initial emergency department diagnosis and management of adult patients with severe sepsis and septic shock |
| Q24201046 | Insulin for glycaemic control in acute ischaemic stroke |
| Q24234214 | Insulin for glycaemic control in acute ischaemic stroke |
| Q47662643 | Insulin infusion for hyperglycaemia in very preterm infants appears safe with no effect on morbidity, mortality and long-term neurodevelopmental outcome |
| Q43974530 | Insulin infusion in intensive care: randomized controlled trial |
| Q35939351 | Insulin inhibits hepatocyte iNOS expression induced by cytokines by an Akt-dependent mechanism |
| Q37921908 | Insulin therapy during hospitalization |
| Q37082032 | Insulin therapy for the management of hyperglycemia in hospitalized patients |
| Q40646639 | Insulin-dependent diabetes and serious trauma |
| Q33421648 | Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data |
| Q37789585 | Intensive insulin therapy during cardiovascular surgery |
| Q35227777 | Intensive insulin therapy for septic patients: a meta-analysis of randomized controlled trials |
| Q37896745 | Intensive insulin therapy in critically ill hospitalized patients: making it safe and effective |
| Q48309991 | Intensive insulin therapy increases glutathione synthesis rate in surgical ICU patients with stress hyperglycemia |
| Q33653311 | Intensive versus conventional insulin therapy in critically ill neurologic patients. |
| Q84922487 | Intensive versus conventional insulin therapy in nondiabetic patients receiving parenteral nutrition after D2 gastrectomy for gastric cancer: a randomized controlled trial |
| Q85106638 | Intensive versus conventional insulin therapy in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial |
| Q28082385 | Interdisciplinary position statement on management of hyperglycemia in peri-operative and intensive care |
| Q38248149 | International multidisciplinary consensus conference on multimodality monitoring: ICU processes of care |
| Q39197605 | International recommendations for glucose control in adult non diabetic critically ill patients |
| Q57175320 | Intraoperative hyperglycemia is independently associated with infectious complications after non-cardiac surgery |
| Q90745039 | Is intensive glucose control bad for critically ill patients? A systematic review and meta-analysis |
| Q94593004 | Is it Necessary to Measure Blood Glucose Level Before and After Colonoscopy in Diabetic and Nondiabetic Patients? |
| Q39016324 | Is management of hyperglycaemia in acute phase stroke still a dilemma? |
| Q39980377 | Is reducing variability of blood glucose the real but hidden target of intensive insulin therapy? |
| Q36374407 | Is there an association between hyperglycemia and clinical outcome in adult patients receiving extracorporeal membrane oxygenation |
| Q38149365 | Life-threatening infections in medically immunocompromised patients |
| Q24282606 | Limitations of medical research and evidence at the patient-clinician encounter scale |
| Q47643834 | Lipopolysaccharide Potentiates Insulin-Driven Hypoglycemic Shock. |
| Q36800765 | Literature review and global consensus on management of acute radiation syndrome affecting nonhematopoietic organ systems |
| Q36963353 | Low-event-rate meta-analyses of clinical trials: implementing good practices |
| Q34258750 | Lower blood glucose and variability are associated with earlier recovery from renal injury caused by episodic urinary tract infection in advanced type 2 diabetic chronic kidney disease |
| Q38530436 | Management of Hyperglycemia and Enteral Nutrition in the Hospitalized Patient |
| Q37697567 | Management of critically ill patients with diabetes |
| Q37956543 | Management of hyperglycemia during the perioperative period |
| Q38129190 | Management of the hospitalized patient with type 1 diabetes mellitus |
| Q37102861 | Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes |
| Q51587667 | Managing CAP in the ICU. |
| Q38241848 | Medanta insulin protocols in patients undergoing cardiac surgery |
| Q45574872 | Metabolic vs nutrition support: a hypothesis |
| Q36693950 | Modeling Inpatient Glucose Management Programs on Hospital Infection Control Programs: An Infrastructural Model of Excellence |
| Q43228287 | Moderate Hypoglycemia is associated with vasospasm, cerebral infarction, and 3-month disability after subarachnoid hemorrhage |
| Q36925816 | Moderate glucose control results in less negative nitrogen balances in medical intensive care unit patients: a randomized, controlled study |
| Q42577172 | Molecular mechanisms of hyperglycemia and cardiovascular-related events in critically ill patients: rationale for the clinical benefits of insulin therapy |
| Q30449427 | Monte Carlo simulation in establishing analytical quality requirements for clinical laboratory tests meeting clinical needs |
| Q35918407 | Multicenter Observational Study of the First-Generation Intravenous Blood Glucose Monitoring System in Hospitalized Patients |
| Q39974347 | NICE-SUGAR: the end of a sweet dream? |
| Q36159133 | Novel approach to inpatient glucometric monitoring and variability in a community hospital setting |
| Q28069270 | Nutrition: A Primary Therapy in Pediatric Acute Respiratory Distress Syndrome |
| Q82224661 | Once is not enough: clinical trials in sepsis |
| Q26858961 | Optimal glycemic control in neurocritical care patients: a systematic review and meta-analysis |
| Q44313142 | Optimizing Inpatient Glycemic Control with Basal-Bolus Insulin Therapy |
| Q39146485 | PERSPECTIVES ON LEARNING AND CLINICAL PRACTICE IMPROVEMENT FOR DIABETES IN THE HOSPITAL: A REVIEW OF EDUCATIONAL INTERVENTIONS FOR PROVIDERS. |
| Q30543305 | Part 10: Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations |
| Q37315749 | Part 4. Post-cardiac arrest care: 2015 Korean Guidelines for Cardiopulmonary Resuscitation. |
| Q26782578 | Part 8: Post-Cardiac Arrest Care: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care |
| Q37200292 | Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations |
| Q34643889 | Peers, regulators, and professions: the influence of organizations in intensive insulin therapy adoption |
| Q57245180 | Performance of strip-based glucose meters and cassette-based blood gas analyzer for monitoring glucose levels in a surgical intensive care setting |
| Q37016837 | Perioperative Blood Glucose Levels <150 mg/dL are Associated With Improved 5-Year Survival in Patients Undergoing On-Pump Cardiac Surgery: A Prospective, Observational Cohort Study |
| Q47157137 | Perioperative Management of Patients with Diabetes |
| Q37689878 | Perioperative and critical illness dysglycemia--controlling the iceberg |
| Q37689875 | Perioperative blood glucose monitoring in the general surgical population |
| Q38071968 | Perioperative control of blood glucose level in cardiac surgery |
| Q37831831 | Perioperative glucose control: living in uncertain times--Continuing Professional Development |
| Q24200372 | Perioperative glycaemic control for diabetic patients undergoing surgery |
| Q34611450 | Perioperative insulin therapy using a closed-loop artificial endocrine pancreas after hepatic resection |
| Q37335141 | Perioperative intensive insulin therapy using artificial endocrine pancreas in patients undergoing pancreatectomy |
| Q26851806 | Point-of-care blood glucose testing for diabetes care in hospitalized patients: an evidence-based review |
| Q58618148 | Portland Intensive Insulin Therapy During Living Donor Liver Transplantation: Association with Postreperfusion Hyperglycemia and Clinical Outcomes |
| Q37590223 | Post-resuscitation care: current therapeutic concepts |
| Q39022520 | Postinjury Inflammation and Organ Dysfunction |
| Q42757266 | Postoperative glycemic control in cardiac surgery patients. |
| Q33751641 | Postoperative mortality in cancer patients with preexisting diabetes: systematic review and meta-analysis. |
| Q50034658 | Potential link between post-acute ischemic stroke exposure to hypoglycemia and hemorrhagic transformation |
| Q38303079 | Practical implementation of incretin-based therapy in hospitalized patients with type 2 diabetes |
| Q38445068 | Predicting mortality of critically ill patients by blood glucose levels |
| Q47552440 | Predictors of hypoglycemia in hospitalized patients with diabetes mellitus. |
| Q37634355 | Prevention of acute kidney injury and protection of renal function in the intensive care unit. Expert opinion of the Working Group for Nephrology, ESICM. |
| Q33974292 | Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine |
| Q37933154 | Progressive artificial endocrine pancreas: The era of novel perioperative blood glucose control for surgery |
| Q61757039 | Prävention, Diagnose, Therapie und Nachsorge der Sepsis |
| Q41540754 | Questionnaire survey on the use of a novel artificial pancreas by intensive care unit nurses |
| Q35973242 | Randomized Controlled Trial of Intensive Versus Conservative Glucose Control in Patients Undergoing Coronary Artery Bypass Graft Surgery: GLUCO-CABG Trial |
| Q37797332 | Real-time glucose monitoring in the hospital: future or now? |
| Q37776864 | Recent Advances in Critical Care Medicine Relevant to Cardiac Surgery |
| Q38068962 | Recommendations for identifying Crohn's disease patients with poor prognosis |
| Q37453086 | Reducing glycemic variability in intensive care unit patients: a new therapeutic target? |
| Q37778214 | Reexamining the evidence for inpatient glucose control: New recommendations for glycemic targets |
| Q93609063 | References |
| Q42793531 | Regulatory controversies surround blood glucose monitoring devices |
| Q37335146 | Relationship between perioperative glycemic control and postoperative infections |
| Q36056039 | Relationship of hyperglycemia and surgical-site infection in orthopaedic surgery |
| Q36965727 | Research studies that have influenced practice of neuroanesthesiology in recent years: A literature review |
| Q94460573 | Risk and reward: extending stochastic glycaemic control intervals to reduce workload |
| Q34505059 | Risk factors for hospital-acquired ‘poor glycemic control’: a case–control study |
| Q84831153 | Risk factors for hypoglycaemia in neurocritical care patients |
| Q36605674 | Risk factors for inpatient hypoglycemia during subcutaneous insulin therapy in non-critically ill patients with type 2 diabetes |
| Q43231824 | Rosiglitazone may assist with glycemic control in the ICU. |
| Q42910493 | Safety and effectiveness of intensive insulin protocol use in post-operative liver transplant recipients |
| Q87393334 | Section 3: Prevention and Treatment of AKI |
| Q56968122 | Selected Medical Errors in the Intensive Care Unit |
| Q33653364 | Sepsis and pregnancy: do we know how to treat this situation? |
| Q34630203 | Sepsis bundles and compliance with clinical guidelines. |
| Q37186378 | Sepsis in pregnancy and early goal-directed therapy |
| Q37655890 | Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding |
| Q35996017 | Serum glucose levels for predicting death in patients admitted to hospital for community acquired pneumonia: prospective cohort study |
| Q37640679 | Severe sepsis and septic shock in the elderly: An overview. |
| Q90458561 | Sialochemical analysis in polytraumatized patients in intensive care units |
| Q33638034 | Social, organizational, and contextual characteristics of clinical decision support systems for intensive insulin therapy: a literature review and case study |
| Q37036416 | Standards of medical care in diabetes--2009. |
| Q33554238 | Standards of medical care in diabetes--2010. |
| Q34425055 | Standards of medical care in diabetes--2011. |
| Q24632533 | Standards of medical care in diabetes--2012 |
| Q29620309 | Standards of medical care in diabetes--2013 |
| Q37493834 | Stress hyperglycaemia |
| Q38087433 | Stress hyperglycemia: an essential survival response! |
| Q47395126 | Strict blood glucose control by an artificial endocrine pancreas during hepatectomy may prevent postoperative acute kidney injury |
| Q55209056 | Strict glycemic control to prevent surgical site infections in gastroenterological surgery. |
| Q44577161 | Subcutaneous versus intravenous insulin therapy for glucose control in non-diabetic trauma patients. A randomized controlled trial |
| Q45995143 | Subjecting acute ischemic stroke patients to continuous tube feeding and an intensive computerized protocol establishes tight glycemic control. |
| Q30428584 | Superiority of moderate control of hyperglycemia to tight control in patients undergoing coronary artery bypass grafting |
| Q46560091 | Surprising result after evaluating a nurse-driven guideline on blood glucose management |
| Q38433744 | Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. |
| Q29615429 | Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012 |
| Q33752318 | Systemic glucose variability predicts cerebral metabolic distress and mortality after subarachnoid hemorrhage: a retrospective observational study |
| Q36954322 | Technical challenges and clinical outcomes of using a closed-loop glycemic control system in the hospital |
| Q89144346 | The Cauldron: Desert Island ICU: (Organised by the Trainee Committee) |
| Q36252427 | The Clinical Benefits and Accuracy of Continuous Glucose Monitoring Systems in Critically Ill Patients-A Systematic Scoping Review |
| Q37729333 | The Glyoxalase System and Methylglyoxal-Derived Carbonyl Stress in Sepsis: Glycotoxic Aspects of Sepsis Pathophysiology |
| Q36825585 | The association between blood glucose levels and matrix-metalloproteinase-9 in early severe sepsis and septic shock |
| Q28081397 | The benefits of tight glycemic control in critical illness: Sweeter than assumed? |
| Q37987391 | The correlation between peri-operative hyperglycemia and mortality in cardiac surgery patients: a systematic review |
| Q51371927 | The danger of using inappropriate point-of-care glucose meters in patients on icodextrin dialysis. |
| Q34503926 | The effect of tight glycaemic control, during and after cardiac surgery, on patient mortality and morbidity: A systematic review and meta-analysis |
| Q37972512 | The effectiveness of a computerized IV infusion protocol to treat hyperglycemia in burn patients |
| Q49401699 | The glucoregulatory benefits of glucagon-like peptide-1 (7-36) amide infusion during intensive insulin therapy in critically ill surgical patients: a pilot study |
| Q38103776 | The impact of diabetes counseling and education: clinical and cost outcomes from a large population of US managed care patients with type 2 diabetes |
| Q37279886 | The impact of early hypoglycemia and blood glucose variability on outcome in critical illness |
| Q41971605 | The impact of hypoglycaemia on patients admitted to hospital with medical emergencies |
| Q48216139 | The influence of pre-admission hypoglycaemic therapy on cardiac morbidity and mortality in type 2 diabetic patients undergoing major non-cardiac surgery: a prospective observational study. |
| Q38212536 | The management of severe community acquired pneumonia in the intensive care unit |
| Q39154147 | The optimal blood glucose level for critically ill adult patients. |
| Q38968055 | The optimal target for acute glycemic control in critically ill patients: a network meta-analysis |
| Q42336264 | The prevention of acute kidney injury: an in-depth narrative review Part 1: volume resuscitation and avoidance of drug- and nephrotoxin-induced AKI |
| Q37792311 | The role of hyperglycemia in acute illness: Supporting evidence and its limitations |
| Q39205383 | The role of insulin therapy and glucose normalisation in patients with acute coronary syndrome |
| Q38187004 | The use of non-insulin anti-diabetic agents to improve glycemia without hypoglycemia in the hospital setting: focus on incretins |
| Q42000049 | Therapeutic effect of insulin in reducing critical illness; polyneuropathy and myopathy in the pediatric intensive care unit |
| Q43289946 | Therapy: Intensive glucose control in the ICU: is sugar nice? |
| Q37925584 | Tight blood glucose control in trauma patients: Who really benefits? |
| Q87091142 | Tight computerized versus conventional glucose control in the ICU: a randomized controlled trial |
| Q93608200 | Tight glucose control: is there any influence on outcome? A retrospective cohort study |
| Q43099043 | Tight glycaemic control in the critically ill: losing its grip? |
| Q38379445 | Tight glycemic control and cardiovascular effects in type 2 diabetic patients |
| Q37305269 | Tight glycemic control and computerized decision-support systems: a systematic review |
| Q47303522 | Tight glycemic control in critically Ill pediatric patients: A meta-analysis and systematic review of randomized controlled trials |
| Q88797067 | Tight glycemic control in critically ill pediatric patients: a meta-analysis and systematic review of randomized controlled trials |
| Q52676100 | Tight glycemic control in critically ill pediatric patients: a systematic review and meta-analysis. |
| Q37106033 | Tight perioperative glucose control is associated with a reduction in renal impairment and renal failure in non-diabetic cardiac surgical patients |
| Q37663614 | Tight perioperative glycemic control using an artificial endocrine pancreas |
| Q85614057 | Toward a guided approach to platelet activation in diabetes |
| Q64055814 | Transcription Errors of Blood Glucose Values and Insulin Errors in an Intensive Care Unit: Secondary Data Analysis Toward Electronic Medical Record-Glucometer Interoperability |
| Q60707270 | Tratamiento de la hiperglucemia en el hospital |
| Q52356001 | Traumatic Brain Injury: At the Crossroads of Neuropathology and Common Metabolic Endocrinopathies. |
| Q37911167 | Treating hyperglycemia in the critically ill child: is there enough evidence? |
| Q38175892 | Treatment of endocrine disorders in the neuroscience intensive care unit |
| Q84700888 | Treatment of polytrauma in the intensive care unit |
| Q35708706 | U-shaped relationship between early blood glucose and mortality in critically ill children |
| Q61698279 | Uncertainties in the measurement of blood glucose in paediatric intensive care: implications for clinical trials of tight glycaemic control |
| Q33626487 | Uncovering the predictive value of minimum blood glucose through statistical analysis of a large clinical dataset |
| Q37876075 | Understanding glycemic control in the critically ill: 2011 update |
| Q41899533 | Understanding hypoglycemia in hospitalized patients |
| Q33830336 | Untangling glycaemia and mortality in critical care |
| Q47847530 | Urinary interleukin-18 and urinary neutrophil gelatinase-associated lipocalin predict acute kidney injury following pulmonary valve replacement prior to serum creatinine. |
| Q37193475 | Validity of meta-analysis in diabetes: meta-analysis is an indispensable tool in evidence synthesis |
| Q36995097 | Value of continuous glucose monitoring for minimizing severe hypoglycemia during tight glycemic control |
| Q47129876 | WHEN LESS IS MORE IN THE INTENSIVE CARE UNIT; LESSONS LEARNED. |
| Q43136687 | What is a NICE-SUGAR for patients in the intensive care unit? |
| Q37623073 | Year in review 2008: Critical Care--metabolism |
| Q85725413 | [Antihyperglycaemic therapy in critically ill patients] |
| Q84276766 | [General planning for the maintenance of the organ donor] |
| Q95443970 | [Guidelines for specialized nutritional and metabolic support in the critically-ill patient. Update. Consensus of the Spanish Society of Intensive Care Medicine and Coronary Units-Spanish Society of Parenteral and Enteral Nutrition (SEMICYUC-SENPE): |
| Q34621790 | [Prevention and follow-up care of sepsis. 1st revision of S2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V., DSG) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine (Deutsche Interdiszi |
| Q45988709 | [Supportive and adjunctive sepsis therapy]. |
| Q89134642 | [Treatment of hyperglycemia in adult, critically ill patients] |
| Q26829973 | 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Associat |
Search more.